Publicacións en colaboración con investigadores/as de Hospital Universitario La Paz (9)

2026

  1. MesenSistem-EB: systemic haploidentical mesenchymal stem cell therapy in recessive dystrophic epidermolysis bullosa associated with clinical benefits and correlated with MCP1 and sCD40L dynamics

    Frontiers in Immunology, Vol. 17, Núm. 9, pp. 1-19

  2. Zinc as a Biomarker of Nutritional Status and Clinical Burden in Recessive Dystrophic Epidermolysis Bullosa: Implications for Preventive Monitoring

    Nutrients , Vol. 18, Núm. 2

2025

  1. Interplay between iron metabolism, inflammation, and EPO-ERFE-hepcidin axis in RDEB-associated chronic anemia

    Blood Advances, Vol. 9, Núm. 9, pp. 2321-2335

2024

  1. Unveiling the value of C-reactive protein as a severity biomarker and the IL4/IL13 pathway as a therapeutic target in recessive dystrophic epidermolysis bullosa: A multiparametric cross-sectional study

    Experimental Dermatology, Vol. 33, Núm. 8

2023

  1. Gluten-sensitive enteropathy in recessive dystrophic epidermolysis bullosa

    British Journal of Dermatology, Vol. 189, Núm. 6, pp. 774-776

2020

  1. Beneficial Effect of Systemic Allogeneic Adipose Derived Mesenchymal Cells on the Clinical, Inflammatory and Immunologic Status of a Patient With Recessive Dystrophic Epidermolysis Bullosa: A Case Report

    Frontiers in Medicine, Vol. 7

2017

  1. BMP4 induces M2 macrophage polarization and favors tumor progression in bladder cancer

    Clinical Cancer Research, Vol. 23, Núm. 23, pp. 7388-7399

2011

  1. Low doses of bone morphogenetic protein 4 increase the survival of human adipose-derived stem cells maintaining their stemness and multipotency

    Stem Cells and Development, Vol. 20, Núm. 6, pp. 1011-1019

2010

  1. Mesenchymal stem cells: Biological properties and clinical applications

    Expert Opinion on Biological Therapy, Vol. 10, Núm. 10, pp. 1453-1468